Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 67

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 67
---
 Are any of the Proposals conditioned on one another? |

| Q: | How will the Initial Shareholders vote? |

26

| proposals (the “Letter Agreement”). In addition, in connection with the execution of the Merger Agreement, the Initial Shareholders entered into the Sponsor Support Agreement with                                                                      
 Semnur, pursuant to which they agreed to vote all Denali Ordinary Shares beneficially owned by them in favor of the Proposals. As of the date of this proxy statement/prospectus, a total of 2,072,500 Denali Ordinary Shares, or approximately 79.2% of 
 the issued and outstanding Denali Ordinary Shares, were subject to the Letter Agreement and the Sponsor Support Agreement. As a result, no Denali Class A Ordinary Shares held by the public shareholders will need to be present in person or by        
 proxy to satisfy the quorum requirement for the Meeting. In addition, as the vote to approve the Business Combination Proposal is the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and       
 entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof, assuming only the minimum number of Denali Ordinary Shares to constitute a quorum is present, none of the issued and outstanding Denali Class A         
 Ordinary Shares held by the public shareholders must be voted in favor of the Business Combination Proposal for it to be approved.                                                                                                                       |

| Q: | How many votes do I have at the Meeting? |

| Q: | Who may vote at the Meeting? |

| A: | Only holders of record of Denali Ordinary Shares as of the close of business on August 12, 2025 may vote                                                                                                                                            
 at the Meeting. As of August 12, 2025, there were 2,616,239 Denali Ordinary Shares (consisting of 29,117 Denali Class A Ordinary Shares, 14,622 Denali Class A Ordinary Shares underlying the Public Units, 510,000 Denali Private Placement Shares 
 underlying the Denali Private Placement Units and 2,062,500 Denali Class B Ordinary Shares) issued and outstanding and entitled to vote. Please see “The Meeting — Record Date; Who is Entitled to                                                  
 Vote” for further information.                                                                                                                                                                                                                      |

| Q: | Am I required to vote against the Business Combination Proposal in order to have my public shares redeemed? |

| A: | No. You are not required to vote